← back to search

Marcio H. Malogolowkin

UC Davis Comprehensive Cancer Center · US
🔎 Find collaborators in Hepatology · Neurology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Hepatology · Neurology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Neuroblastoma Research and Treatments, Renal and related cancers, and Childhood Cancer Survivors' Quality of Life.
h-index
48
citations
8,309
works
174
NIH funding
primary concept
Medicine
email

Recent publications

Global consensus from the PHITT consortium surrounding an interim chemotherapy guidance for the treatment of children with hepatoblastoma, hepatocellular neoplasm – not otherwise specified (HCN-NOS), hepatocellular carcinoma and fibrolamellar carcinoma after trial closure
EJC Paediatric Oncology 2025cited by 5position: middledoi
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2023cited by 126position: middledoi
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5
Cancer 2023cited by 19position: middledoi
Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC)
Pediatric Blood & Cancer 2023cited by 17position: middledoi
Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731
Journal of Pediatric Surgery 2022cited by 28position: middledoi
Impact of location of inpatient cancer care on patients with Ewing sarcoma and osteosarcoma—A population‐based study
Pediatric Blood & Cancer 2021cited by 8position: middledoi
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database
Pediatric Blood & Cancer 2020cited by 58position: middledoi
Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial
The Lancet Oncology 2019cited by 113position: middledoi
Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children’s oncology group AHEP 0731 liver tumor committee
Journal of Pediatric Surgery 2019cited by 41position: middledoi
Decreased Early Mortality in Young Adults with Acute Lymphoblastic Leukemia Treated at Specialized Cancer Centers in California
Blood 2017cited by 3position: middledoi
Mortality in young adults with Ewing sarcoma treated at specialized cancer centers in California.
Journal of Clinical Oncology 2017cited by 2position: middledoi
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration
The Lancet Oncology 2016cited by 436position: middledoi
The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model
European Journal of Cancer 2015cited by 280position: middledoi
Congenital abnormalities and hepatoblastoma: A report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB)
American Journal of Medical Genetics Part A 2014cited by 31position: middledoi
Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium
Modern Pathology 2013cited by 343position: middledoi
Hepatoblastoma state of the art
Current Opinion in Pediatrics 2013cited by 308position: middledoi
Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: A report of the children's oncology group (COG)
Pediatric Blood & Cancer 2013cited by 23position: firstdoi
Hepatoblastoma clinical research: Lessons learned and future challenges
Pediatric Blood & Cancer 2012cited by 68position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark Krailo · University of Southern California8 papers (2013–2023)Rebecka L. Meyers · Primary Children's Hospital8 papers (2013–2023)Dolores López‐Terrada · Baylor College of Medicine7 papers (2013–2023) · 6 papers (2013–2025)Sarangarajan Ranganathan · Cincinnati Children's Hospital Medical Center5 papers (2013–2023)Piotr Czauderna · Texas Children's Hospital5 papers (2013–2023) · 4 papers (2019–2025)Arun Rangaswami · University of California, San Francisco4 papers (2015–2025)Milton J. Finegold · Baylor College of Medicine4 papers (2013–2022)Ivo Leuschner · University of Lübeck4 papers (2013–2023)Howard M. Katzenstein · Ono Pharmaceutical (United States)4 papers (2013–2022)Marc Ansari · Western General Hospital3 papers (2016–2025)Neyssa Marina · Coherus BioSciences (United States)3 papers (2013–2021)Max R. Langham · University of Tennessee at Knoxville3 papers (2019–2022)Giorgio Perilongo · University of Padua3 papers (2012–2016)Theresa H.M. Keegan · UC Davis Comprehensive Cancer Center3 papers (2017–2021)Brad H. Pollock · University of Arizona3 papers (2017–2021)Beate Häberle · Ludwig-Maximilians-Universität München3 papers (2013–2023)Qian Li · University of California, Davis3 papers (2017–2021)Irene Schmid · Molecular Networks (Germany)3 papers (2015–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Hepatology · Neurology →